Welcome!

News Feed Item

DNA Sequencing: Emerging Technologies and Applications

LONDON, April 17, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:

DNA Sequencing: Emerging Technologies and Applications

http://www.reportbuyer.com/pharma_healthcare/biotechnology/technologies/dna_sequencing_emerging_technologies_applications.html

REPORT HIGHLIGHTS

The global market for sequencing products and services reached $3.5 billion in 2012. This market is expected to grow to nearly $4.5 billion in 2013 and nearly 11.7 billion in 2018, a compound annual growth rate (CAGR) of 21.2%.

This report provides:
An overview of the global market for sequencing products and services.
Analyses of global market trends, with data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018.
Quantification of the DNA sequencing markets by product type, platform, customer type,value chain position, analysis type and geography.
A look at substantial future growth opportunities for industry participants including consumer and diagnostic sequencing services, bioinformatics, sequence enrichment, benchtop NGS sequencers and consumables, and emerging sequencing instruments.

STUDY GOALS AND OBJECTIVES

BCC Research's goal for this study is to provide an in-depth analysis of the sequencing industry, an important industry in life sciences with enormous market potential. The approach for analyzing the industry is taken in terms of workflow (e.g., sequencers, sequence capture, informatics) and key applications (e.g., research, applied, services, sample prep, informatics) where sequencing will have market share by 2018.BCC Research examines the markets for sequencing products and services for the years 2012, 2013 and 2018.Special emphasis is placed on the global next-generation sequencing (NGS) diagnostic markets, which are characterized and quantified by disease indication, test complexity, test purpose and geography.Sequencing market segments that provide exciting growth opportunities include benchtop NGS sequencing instruments and consumables; clinical diagnostics (e.g., cancer, rare genetic diseases and prenatal screening); sequencing software; and consumer sequencing services.The report provides a comprehensive discussion of sequencing technologies, market applications, industry structure, important clinical sequencing initiatives, global markets, patent status and companies. The report is designed to aid companies in their strategic planning efforts for accessing sequencing industry opportunities.

REASONS FOR DOING THE STUDY

The Human Genome Project (HGP) moved DNA sequencing technology to the forefront of life science research as a genetic analysis tool. The HGP relied heavily on Sanger sequencing by capillary electrophoresis to decipher the DNA sequence of the bases in the human genome.The HGP led to significant improvements in the efficiency and costs of DNA sequencing. During this time period, the sequencing industry consolidated, resulting in one dominant company, Applied Biosystems (now Life Technologies).Beginning in 2005, the launch of next-generation sequencing technologies radically changed the structure of the industry and opened up exciting new market applications. The costs of sequencing have rapidly reduced to the point where it is now feasible for complex NGS tests to be priced in the range of other multiplex genetic tests.As a result, opportunities for sequencing products and services are emerging in diverse applications ranging, for example, from clinical diagnostics to direct to consumer genetic testing markets.Clinical value has been shown for many applications, and several launched tests are having good commercial success. This shows that both patients and physicians are recognizing the value of NGS tests. Several molecular genetic tests that have been successful on non-NGS formats will run on NGS platforms in the future.At the same time, payors and insurance companies are beginning to provide coverage for these tests, further enhancing their commercial potential.In direct to consumer genetic testing market, there is an emerging trend to move to sequencing of specific genome regions. Compared with microarrays, sequencing provides more comprehensive information to the consumer. Recent product introductions by Full Genomes Corporation and Family Tree DNA using NGS to sequence the full Y chromosome are examples of this trend.These technical and market factors are driving this market so that it is now timely to examine the sequencing markets.

INTENDED AUDIENCE

This report fills a gap in market research as it covers the three main sequencing platforms: Sanger sequencing, NGS and 3GS.The report provides a roadmap for understanding where sequencing is likely to be used in the life sciences during the next five years. As such, it is a useful guide for strategic and business planning, as well as for learning about the impact new sequencing technologies will have in the various market segments.This market report will be useful to many companies involved in the direct to consumer, informatics, clinical, genetic testing and sequencing industries. It will be particularly valuable for companies in such industries as life science research tools, NGS instruments, molecular diagnostics, informatics, clinical laboratories, pharmaceutical, biotechnology, microfluidics, lab-on-a-chip and sample preparation.

SCOPE AND FORMAT

The scope of the report includes sequencing technologies, applications, industries, initiatives, markets, patents and companies. The markets for sequencing products and services are given for the years 2012, 2013 and 2018.This report reviews the main sequencing platforms, and explains why genetic variation is important for many markets, including clinical testing. It then discusses some of the top research initiatives that are contributing to NGS applications. Market driving forces are also discussed.The report covers the sequencing markets by workflow, including sample preparation products; sequencing instruments & consumables; informatics; and sequencing services. It includes the sequencing instrument market by platform: Sanger, NGS and 3GS and by instrument class: low throughput, high-throughput, benchtop, and handheld.The report covers the markets for the main sequencing end use applications, including research (R&D, drug discovery & development, biotech); clinical; consumer; and applied (forensics, microbial genomics, agricultural genomics).A key part of the report covers NGS clinical markets in depth, including by test complexity, indication and test purpose. Test complexity refers to the multiplexing (e.g., the number of genes covered) and coverage (e.g., the extent to which the genome is covered) of the test. Examining the market by test complexity provides valuable insight into which products (e.g., sample preparation, NGS instrument, informatics) will be in demand in the future.The report provides market data and forecasts for NGS diagnostics by specific applications, including those for cancer, rare diseases, common diseases, and pre- and post-natal screening.Specific geographic markets are discussed, including North America, Europe, China, Japan and the rest of the world.Market data covers the years 2012, 2013 and 2018.Industry sectors analyzed in this report include NGS instruments (including market share data for the main instrument companies); NGS target enrichment; 3GS; direct to consumer genetic testing; single cell genomics; NGS-based proteomics; informatics; information technology; clinical laboratory; and the prenatal diagnostics (including market shares for the leading NGS companies).More than 142 companies in the sequencing industry are profiled in this report.BCC Research provides a summary of the main industry acquisitions and strategic alliances from 2011 through 2013, including key alliance trends.

METHODOLOGY

Both primary and secondary research methodologies were used in preparing this study. BCC Research examined each of the key end-user market segments that will be commercially important during the next five years.Based on this analysis, the current and future applications of sequencing technologies are evaluated in each of the major market segments and sales revenues are forecast for 2013 through 2018.Based on analysis of both secondary and primary market sources, as well as the key trends in the industry, the report provides the current and projected market size for the various sequencing market segments for the years 2012, 2013 and 2018.
Chapter- 1: INTRODUCTION
STUDY GOALS AND OBJECTIVES
REASONS FOR DOING THE STUDY
INTENDED AUDIENCE
SCOPE AND FORMAT
METHODOLOGY
INFORMATION SOURCES
RELATED BCC RESEARCH REPORTS
ANALYST CREDENTIALS
BCC RESEARCH ONLINE SERVICES
DISCLAIMER
Chapter- 2: EXECUTIVE SUMMARY
Table Summary : GLOBAL VALUE OF SEQUENCING PRODUCTS AND SERVICES, BY TYPE, THROUGH 2018
Figure Summary : GLOBAL VALUE OF SEQUENCING PRODUCTS AND SERVICES, BY TYPE, 2012–2018
Chapter- 3: OVERVIEW
INTRODUCTION
SEQUENCING MARKET
SEQUENCING PRODUCTS
SEQUENCING PRODUCT LIFE CYCLE STATUS
NEXT-GENERATION SEQUENCING INDUSTRY
Chapter- 4: TECHNOLOGIES
IMPORTANCE OF DNA
GENETIC VARIATION AND ANALYSIS
GENETIC ANALYSIS TECHNOLOGIES
SEQUENCING IN CLINICAL APPLICATIONS
SEQUENCING TECHNOLOGIES
INFORMATICS TECHNOLOGIES
CLINICAL SEQUENCING TECHNOLOGY CHALLENGES
TOP TEN CLINICAL NEXT-GENERATION SEQUENCING INITIATIVES
Chapter- 5: DNA SEQUENCING APPLICATIONS
INTRODUCTION
GENETIC ANALYSIS
DE NOVO WHOLE GENOME SEQUENCING
RESEQUENCING
SEQ-BASED METHODS
STRUCTURAL VARIATION STUDIES
COMPLEMENTARY SEQUENCING AND MICROARRAY PLATFORMS
SEQUENCING END-USE APPLICATIONS
Chapter- 6: CLINICAL NEXT-GENERATION SEQUENCING APPLICATIONS
INTRODUCTION
CANCER APPLICATIONS
MENDELIAN DISORDERS APPLICATIONS
SCREENING APPLICATIONS
INFECTIOUS DISEASE APPLICATIONS
COMMON DISORDERS APPLICATIONS
Chapter- 7: SEQUENCING INDUSTRY
INTRODUCTION
NEXT-GENERATION SEQUENCING INSTRUMENT INDUSTRY
NEXT-GENERATION SEQUENCING TARGET ENRICHMENT INDUSTRY
THIRD GENERATION SEQUENCING INDUSTRY
DIRECT-TO-CONSUMER GENETIC TESTING INDUSTRY
SINGLE CELL GENOMICS INDUSTRY
NGS-BASED PROTEOMICS INDUSTRY
SEQUENCING INFORMATICS INDUSTRY
SEQUENCING INFORMATION TECHNOLOGY INDUSTRY
CLINICAL LABORATORY INDUSTRY
PRENATAL DIAGNOSTICS INDUSTRY
SEQUENCING INDUSTRY ACQUISITIONS AND STRATEGIC ALLIANCES
Chapter- 8: SEQUENCING MARKETS
GROWTH DRIVING FORCES
SEQUENCING MARKET SUMMARY
SEQUENCING INSTRUMENTS AND CONSUMABLES MARKET
SEQUENCING SAMPLE PREP MARKETS
SEQUENCING INFORMATICS MARKET
SEQUENCING SERVICES MARKETS
CLINICAL NGS MARKET
CLINICAL NGS CANCER MARKETS
CLINICAL NGS CARDIOVASCULAR MARKETS
CLINICAL NGS MENDELIAN DISORDERS MARKETS
CLINICAL NGS METABOLIC AND IMMUNE DISORDERS MARKETS
CLINICAL NGS NEUROLOGY MARKETS
CLINICAL NGS NEWBORN SCREENING MARKETS
CLINICAL NGS PRENATAL DIAGNOSTIC MARKETS
CLINICAL NGS FOOD-BORNE ILLNESS MARKETS
CLINICAL NGS HUMAN LEUKOCYTE ANTIGEN TYPING MARKETS
SEQUENCING MARKETS BY GEOGRAPHIC REGION
CLINICAL NGS GEOGRAPHICAL MARKETS
Chapter- 9: CLINICAL NGS PATENTS
CLINICAL NEXT-GENERATION SEQUENCING PATENTS BY INDICATION
CLINICAL NEXT-GENERATION SEQUENCING PATENT ISSUES
Table 127 : CLINICAL NEXT-GENERATION SEQUENCING PATENTS*, 2002-2012
Chapter- 10: COMPANY PROFILES
23ANDME INC.
ADAPTIVE BIOTECHNOLOGIES INC.
AGILENT TECHNOLOGIES INC.
ALMAC GROUP LTD.
AMBRY GENETICS
APPISTRY INC.
ASSURERX HEALTH
ASTRID BIOSCIENCE GMBH
ASURAGEN INC.
AVIIR INC.
BASE4 INNOVATION LTD.
BECKMAN COULTER
BERRY GENOMICS CO. LTD.
BGI
BINA TECHNOLOGIES INC.
BLUEPRINT GENETICS
BOREAL GENOMICS
CAMBRIDGE EPIGENETIX LTD.
CARIS LIFE SCIENCES
CEGAT GMBH
CHRONIX BIOMEDICAL
CLC BIO
CODIFIED GENOMICS LLC
CORIELL LIFE SCIENCES INC.
CORRELAGEN DIAGNOSTICS INC
COUNSYL INC
COURTAGEN LIFE SCIENCES INC
CYNVENIO BIOSYSTEMS INC
CYPHER GENOMICS INC.
DIOGENIX INC.
DNA ELECTRONICS LTD.
DNA LINK
DNANEXUS INC.
EAGLE GENOMICS, LTD.
ELECTRONIC BIOSCIENCES
ENZYMATICS INC.
EUROFINS MWG OPERON
EXIQON A/S
EXOSOME DIAGNOSTICS INC.
EXPRESSION ANALYSIS INC.
FOUNDATION MEDICINE
FULL GENOMES CORPORATION
GATC BIOTECH AG
GE HEALTHCARE
GENAPSYS
GENDX BV
GENE BY GENE LTD.
GENEDX INC.
GENEPEEKS INC.
GENEWIZ INC.
GENIA TECHNOLOGIES INC.
GENOLOGICS LIFE SCIENCES SOFTWARE
GENOMATIX SOFTWARE GMBH
GENOMEQUEST INC.
GENOMIC HEALTH INC.
GIGAGEN INC.
GNUBIO INC.
GOOD START GENETICS INC.
ILLUMINA INC.
INGENUITY SYSTEMS INC.
INNOVATIONS EXCHANGE PTE LTD
INVITAE, INC.
IREPERTOIRE
KAILOS GENETICS
KELLBENX INC.
KNOME INC.
LABORATORY CORPORATION OF AMERICA INC.
LABORATORY FOR MOLECULAR MEDICINE
LASERGEN INC.
LIFE TECHNOLOGIES INC.
MACROGEN INC.
MAVERIX BIOMICS INC.
MD ANDERSON CANCER CENTER
MEDGENOME LABS PVT. LTD.
MEDOMICS LLC.
MIINOME INC.
MULTIPLICOM NV
MYRIAD GENETICS INC.
NABSYS INC.
NATERA INC.
NEWGENE LTD.
NOBLEGEN BIOSCIENCES
N-OF-ONE INC.
NOVARTIS AG
NUMERATE INC.
NXT-DX
OMICIA INC.
OMIXON BIOCOMPUTING KFT
ONCODNA SA
ONCOSPIRE GENOMICS
OXFORD GENE TECHNOLOGY
OXFORD NANOPORE TECHNOLOGIES
PACIFIC BIOSCIENCES OF CALIFORNIA INC.
PARABASE GENOMICS
PASTEL BIOSCIENCE LTD
PATHOGENETIX
PATHOGENICA
PATHOQUEST SAS
PERKIN ELMER INC.
PERSONAL GENOME DIAGNOSTICS INC.
PERSONALIS INC.
PICOSEQ
POPULATION GENETICS TECHNOLOGIES LTD.
PORTABLE GENOMICS LLC
PREVENTIONGENETICS INC.
QIAGEN
QUANTUMDX
RAINDANCE TECHNOLOGIES INC.
REAL TIME GENOMICS INC.
REPROGENETICS
RESPONSE GENETICS INC.
ROCHE HOLDING AG
SCIGENOM LABS
SENGENICS INTERNATIONAL PTE LTD.
SEQUENOM INC.
SEQUENTA INC.
SEQUOIA GENETICS CO. LTD.
SEVEN BRIDGES GENOMICS INC.
SIEMENS AG
SILICON VALLEY BIOSYSTEMS
SINGLE CELL TECHNOLOGY, INC.
SISTEMAS GENOMICOS
SOFTGENETICS LLC
SPIRAL GENETICS INC.
STATION X INC.
STRAND LIFE SCIENCES
STRATOS GENOMICS INC.
SUNDANCE DIAGNOSTICS INC.
SYAPSE
SYGNIS AG
SYNAPDX
THERMO FISHER SCIENTIFIC INC.
TRANSGENOMIC INC.
TROVAGENE INC.
TUTE GENOMICS, INC.
TWO PORE GUYS INC.
WARP DRIVE BIO LLC
YIKON GENOMICS CO. LTD.
ZS GENETICS
ZYMO RESEARCH CORPORATION

Read the full report:
DNA Sequencing: Emerging Technologies and Applications

http://www.reportbuyer.com/pharma_healthcare/biotechnology/technologies/dna_sequencing_emerging_technologies_applications.html

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]  
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

SOURCE ReportBuyer

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
SYS-CON Events announced today that Golden Gate University will exhibit at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Since 1901, non-profit Golden Gate University (GGU) has been helping adults achieve their professional goals by providing high quality, practice-based undergraduate and graduate educational programs in law, taxation, business and related professions. Many of its courses are taug...
@DevOpsSummit at Cloud Expo taking place Oct 31 - Nov 2, 2017, at the Santa Clara Convention Center, Santa Clara, CA, is co-located with the 21st International Cloud Expo and will feature technical sessions from a rock star conference faculty and the leading industry players in the world. The widespread success of cloud computing is driving the DevOps revolution in enterprise IT. Now as never before, development teams must communicate and collaborate in a dynamic, 24/7/365 environment. There is ...
The question before companies today is not whether to become intelligent, it’s a question of how and how fast. The key is to adopt and deploy an intelligent application strategy while simultaneously preparing to scale that intelligence. In her session at 21st Cloud Expo, Sangeeta Chakraborty, Chief Customer Officer at Ayasdi, will provide a tactical framework to become a truly intelligent enterprise, including how to identify the right applications for AI, how to build a Center of Excellence to...
DevOps at Cloud Expo, taking place October 31 - November 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA, is co-located with 21st Cloud Expo and will feature technical sessions from a rock star conference faculty and the leading industry players in the world. The widespread success of cloud computing is driving the DevOps revolution in enterprise IT. Now as never before, development teams must communicate and collaborate in a dynamic, 24/7/365 environment. There is no time to w...
"We provide IoT solutions. We provide the most compatible solutions for many applications. Our solutions are industry agnostic and also protocol agnostic," explained Richard Han, Head of Sales and Marketing and Engineering at Systena America, in this SYS-CON.tv interview at @ThingsExpo, held June 6-8, 2017, at the Javits Center in New York City, NY.
Given the popularity of the containers, further investment in the telco/cable industry is needed to transition existing VM-based solutions to containerized cloud native deployments. The networking architecture of the solution isolates the network traffic into different network planes (e.g., management, control, and media). This naturally makes support for multiple interfaces in container orchestration engines an indispensable requirement.
SYS-CON Events announced today that DXWorldExpo has been named “Global Sponsor” of SYS-CON's 21st International Cloud Expo, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Digital Transformation is the key issue driving the global enterprise IT business. Digital Transformation is most prominent among Global 2000 enterprises and government institutions.
21st International Cloud Expo, taking place October 31 - November 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA, will feature technical sessions from a rock star conference faculty and the leading industry players in the world. Cloud computing is now being embraced by a majority of enterprises of all sizes. Yesterday's debate about public vs. private has transformed into the reality of hybrid cloud: a recent survey shows that 74% of enterprises have a hybrid cloud strategy. Me...
yperConvergence came to market with the objective of being simple, flexible and to help drive down operating expenses. It reduced the footprint by bundling the compute/storage/network into one box. This brought a new set of challenges as the HyperConverged vendors are very focused on their own proprietary building blocks. If you want to scale in a certain way, let’s say you identified a need for more storage and want to add a device that is not sold by the HyperConverged vendor, forget about it....
With Cloud Foundry you can easily deploy and use apps utilizing websocket technology, but not everybody realizes that scaling them out is not that trivial. In his session at 21st Cloud Expo, Roman Swoszowski, CTO and VP, Cloud Foundry Services, at Grape Up, will show you an example of how to deal with this issue. He will demonstrate a cloud-native Spring Boot app running in Cloud Foundry and communicating with clients over websocket protocol that can be easily scaled horizontally and coordinate...
In his session at 20th Cloud Expo, Scott Davis, CTO of Embotics, discussed how automation can provide the dynamic management required to cost-effectively deliver microservices and container solutions at scale. He also discussed how flexible automation is the key to effectively bridging and seamlessly coordinating both IT and developer needs for component orchestration across disparate clouds – an increasingly important requirement at today’s multi-cloud enterprise.
Any startup has to have a clear go –to-market strategy from the beginning. Similarly, any data science project has to have a go to production strategy from its first days, so it could go beyond proof-of-concept. Machine learning and artificial intelligence in production would result in hundreds of training pipelines and machine learning models that are continuously revised by teams of data scientists and seamlessly connected with web applications for tenants and users.
Vulnerability management is vital for large companies that need to secure containers across thousands of hosts, but many struggle to understand how exposed they are when they discover a new high security vulnerability. In his session at 21st Cloud Expo, John Morello, CTO of Twistlock, will address this pressing concern by introducing the concept of the “Vulnerability Risk Tree API,” which brings all the data together in a simple REST endpoint, allowing companies to easily grasp the severity of t...
Recently, WebRTC has a lot of eyes from market. The use cases of WebRTC are expanding - video chat, online education, online health care etc. Not only for human-to-human communication, but also IoT use cases such as machine to human use cases can be seen recently. One of the typical use-case is remote camera monitoring. With WebRTC, people can have interoperability and flexibility for deploying monitoring service. However, the benefit of WebRTC for IoT is not only its convenience and interopera...
IT organizations are moving to the cloud in hopes to approve efficiency, increase agility and save money. Migrating workloads might seem like a simple task, but what many businesses don’t realize is that application migration criteria differs across organizations, making it difficult for architects to arrive at an accurate TCO number. In his session at 21st Cloud Expo, Joe Kinsella, CTO of CloudHealth Technologies, will offer a systematic approach to understanding the TCO of a cloud application...